CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Sachdev Amit EVP, Chief Patient Officer | Grant or award | +7,866 | 79,752 | ||
| 2023-02-01 | LEIDEN JEFFREY M Executive Chairman | Grant or award | +31,462 | 33,885 | ||
| 2023-02-01 | LEIDEN JEFFREY M Executive Chairman | Grant or award | +34,890 | 68,775 | ||
| 2023-02-01 | LEIDEN JEFFREY M Executive Chairman | Grant or award | +10,226 | 79,001 | ||
| 2023-02-01 | Kewalramani Reshma CEO & President | Grant or award | +12,388 | 101,986 | ||
| 2023-02-01 | Kewalramani Reshma CEO & President | Grant or award | +29,118 | 131,104 | ||
| 2023-02-01 | Kewalramani Reshma CEO & President | Grant or award | +26,972 | 158,076 | ||
| 2023-02-01 | Bozic Carmen EVP and CMO | Grant or award | +10,324 | 59,836 | ||
| 2023-02-01 | Bozic Carmen EVP and CMO | Grant or award | +10,262 | 70,098 | ||
| 2023-02-01 | Bozic Carmen EVP and CMO | Grant or award | +7,866 | 77,964 | ||
| 2023-02-01 | Biller Jonathan EVP and Chief Legal Officer | Grant or award | +6,293 | 11,587 | ||
| 2023-02-01 | Arbuckle Stuart A EVP, COO | Grant or award | +12,388 | 70,419 | ||
| 2023-02-01 | Arbuckle Stuart A EVP, COO | Grant or award | +14,624 | 85,043 | ||
| 2023-02-01 | Arbuckle Stuart A EVP, COO | Grant or award | +11,209 | 96,252 | ||
| 2023-02-01 | Ambrose Kristen SVP & Chief Accounting Officer | Grant or award | +2,566 | 6,062 | ||
| 2023-02-01 | Ambrose Kristen SVP & Chief Accounting Officer | Grant or award | +2,950 | 9,012 | ||
| 2023-02-01 | ALTSHULER DAVID EVP, Global Research and CSO | Grant or award | +12,388 | 48,465 | ||
| 2023-02-01 | ALTSHULER DAVID EVP, Global Research and CSO | Grant or award | +12,314 | 60,779 | ||
| 2023-02-01 | ALTSHULER DAVID EVP, Global Research and CSO | Grant or award | +7,866 | 68,645 | ||
| 2023-01-31 | Sanna Bastiano EVP, Cell & Genetic Therapies | Sale | −106 | $325.00 | $34K | 37,998 |
Page 39 of 40 · 781 trades